Compound Summary
Compound Name: | 			(-)-p-Bromotetramisole oxalate | 
Compound CID: | 			2724023 | 
Synonyms: | 			(-)-p-Bromotetramisole oxalate 62284-79-1 L-p-BROMOTETRAMISOLE OXALATE S(-)-p-Bromotetramisole oxalate L-(-)-p-Bromotetramisole oxalate More... | 
Iupac Name: | 			(6S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;oxalic acid | 
InChI: | 					InChI=1S/C11H11BrN2S.C2H2O4/c12-9-3-1-8(2-4-9)10-7-14-5-6-15-11(14)13-10;3-1(4)2(5)6/h1-4,10H,5-7H2;(H,3,4)(H,5,6)/t10-;/m1./s1 | 
InChIKey: | 				ZULBIBHDIQCNIS-HNCPQSOCSA-N | 
Canonical Smiles: | 		C1CSC2=NC(CN21)C3=CC=C(C=C3)Br.C(=O)(C(=O)O)O | 
Isomeric Smiles: | 			C1CSC2=N[C@H](CN21)C3=CC=C(C=C3)Br.C(=O)(C(=O)O)O | 
Molecular Weight: | 		373.22 | 
Molecular Formula: | 			C13H13BrN2O4S | 
Molecular Weight: | 		373.22 | 
Molecular Formula: | 			C13H13BrN2O4S | 
Hydrogen Bond Donor Count: | 			2 | 
Hydrogen Bond Acceptor Count: | 			6 | 
Rotatable Bond Count: | 			2 | 
Heavy Atom Count: | 					21 | 
Complexity: | 				345 | 
| (-)-p-Bromotetramisole oxalate | (-)-p-Bromotetramisole oxalate | 
|---|---|
(-)-p-Bromotetramisole oxalate | 			
62284-79-1 | 
L-p-BROMOTETRAMISOLE OXALATE | 			
S(-)-p-Bromotetramisole oxalate | 
L-(-)-p-Bromotetramisole oxalate | 			
(S)-(-)-4-Bromotetramisole oxalate | 
(-)-p-Bromolevamisole oxalate | 			
(-)-p-Bromotetramisole (oxalate) | 
(S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo2,1-bthiazole oxalate | 			
6-Bromolevamisole oxalate | 
6-Bromolevamisole oxalate salt | 			
C11H11BrN2S.C2H2O4 | 
(-)-4-Bromotetramisole oxalate salt | 			
R 30402 oxalate | 
EU-0100021 | 			
()-p-Bromolevamisole oxalate | 
BMK1-H3 | 			
MLS000860040 | 
CHEMBL1256792 | 			
Bromotetramisole, L-(-) oxalate | 
HMS2231M14 | 			
HMS3260E03 | 
BCP16717 | 			
Tox21_500021 | 
(-)-p-Bromolevamisole oxalate 99% | 			
2125AH | 
s7383 | 			
(-)-p-Bromolevamisole oxalate, 99% | 
CCG-221325 | 			
CS-5385 | 
LP00021 | 			
(S)-(-)-6-(4-Bromophenyl)-2,3,5,6-tetrahydroimidazo2,1-bthiazole oxalate salt | 
NCGC00093544-01 | 			
NCGC00260706-01 | 
AS-72721 | 			
BC003102 | 
HY-19695 | 			
SMR000326898 | 
MLS-0317970.P017 | 			
ST50308584 | 
SW220284-1 | 			
A14271 | 
C75926 | 			
SR-01000075599 | 
SR-01000075599-1 | 			
(6S)-6-(4-BROMOPHENYL)-2H,3H,5H,6H-IMIDAZO2,1-B1,3THIAZOLE; OXALIC ACID | 
(6S)-6-(4-bromophenyl)-2H,3H-2-imidazolino2,1-b1,3-thiazolidine, ethanedioic acid | 			
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 12.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 12.000000000000000 | 1 | 1 |